IVRHA 2022: Exhibiting pioneers of medical XR
pharmaphorum
MARCH 21, 2022
In 2021, the behavioural health company and Sumitomo Dainippon Pharma Co. in Japan announced their partnership to develop and commercialise prescription digital therapeutics and general wellness products to treat social anxiety disorder, generalised anxiety, and major depressive disorder. About the author .
Let's personalize your content